Bradley Robinson

Chief Executive Officer / Director

Brad Robinson serves as the chief executive officer of Predictive Technology Group. Mr. Robinson has more than 15 years of experience in operational, transactional, business development and financing across multiple sectors within the biopharmaceutical industry. He was a founding member of LifeCode Genetics, LLC., in 2011 and Predictive Therapeutics, LLC., in 2013, both of which are now wholly-owned subsidiaries of Predictive Technology Group. Prior to Predictive, Mr. Robinson was vice president of business development at Juneau BioSciences. He has been a founding member of other ventures in healthcare, one of which (Specialized Health Products International, Inc.) was publicly traded until its acquisition in March 2008 by C.R. Bard. He was also the chief executive officer and co-founder of Infusive Technologies, LLC. from November 2004 until September 2008 when it was acquired by Sagent Pharmaceuticals, Inc. As part of the acquisition, he served as president of the medical device division of Sagent Pharmaceuticals. Mr. Robinson received his master’s degree in business administration and management from the University of Utah.